Cite

HARVARD Citation

    Watts, P. et al. (2021). A retrospective analysis of bleeding risk with rivaroxaban, enoxaparin, and aspirin following total joint arthroplasty or revision. Pharmacotherapy. 41 (7), pp. 608-615. [Online]. 
  
Back to record